|本期目录/Table of Contents|

[1]雷军平,曹江晨综述,郑 兴审校.Mimecan/Osteoglycin与心血管疾病[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):52-54.
点击复制

Mimecan/Osteoglycin与心血管疾病()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第14卷
期数:
2012年01期
页码:
52-54
栏目:
综述
出版日期:
2012-01-20

文章信息/Info

Title:
-
文章编号:
1672-271X(2012)01-0052-03
作者:
雷军平1; 曹江晨2综述; 郑 兴1审校
1.200433 上海，长海医院心血管内科; 2.214063 江苏无锡,解放军73801部队门诊部
Author(s):
-
关键词:
心血管疾病;  Mimecan
Keywords:
-
分类号:
R541
DOI:
-
文献标志码:
A
摘要:
Mimecan/Osteoglycin(OGN)是一种细胞外基质蛋白，主要由Osteoglycin基因编码而成，在动脉的生长与发育，在动脉粥样硬化病理生理、心肌细胞的增殖及心脏功能等方面发挥重要作用。
Abstract:
-

参考文献/References:

[1]Funderburgh JL,Corpuz LM,Roth MR,et al.Mimecan,the 25-kDa corneal keratan sulfate proteoglycan,is a product of the gene producing osteoglycin[J].J Biol Chem，1997,272(44):28089-28095.
[2]Tasheva ES,Pettenati M,Von Kap-Her C,et al.Assignment of mi-mecan gene(OGN)to human chromosome band 9q22 by in situ hybridization[J].Cytogenet Cell Genet,2000,88(3-4):326-327.
[3]McEwan PA,Scott PG,Bishop PN,et al.Structural correlations in the family of small leucine-rich repeat proteins and proteogly-cans[J].JStruct Biol,2006,155(2):294-305.
[4]Elena S，Tasheva,An Ke,et al.Differentially expressed genes in the lens of mimecan-null mice[J].Mol Vis,2004,17(10):403-416.
[5]Ge G,Seo NS,Liang X,et al.Bone morphogenetic protein-1/tol-loid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis[J].J Biol Chem,2004,279(40):41626-41633.
[6]Moseley R,Stewart JE,Stephens P,et al.Extracellularmatrix metabolites as potential biomarkers of disease activiyin wound fluid lessons learned from other inflammatory diseases[J].Br J Dermatol,2004,150(3):401-413.
[7]Shanahan CM,Cary NR,Osbourn JK,et al.Identification of osteoglycin as a component of the vascular matrix:differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques[J].Arterioscler Thromb Vasc Biol,1997,17(11):2437-2447.
[8]Gu XS,Lei JP,Shi JB,et al.Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats[J].Mol Cell Biochem,2011，352(1-2):309-316.
[9]Wu-Wong JR,Nakane M,Ma J,et al.VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells[J].J Cell Biochem，2007,100(6):1395-1405.
[10]Kampmann A,Fernández B,Deindl E,et al.The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis[J].Mol Cell Biochem,2009,322(1-2):15-23.
[11]罗助秉.骨保护素系统与动脉粥样硬化的研究进展[J].东南国防医药，2010，12(6):523-525.
[12]花雪琴，顾 青，张 诚,等.150例中心性肥胖者颈总动脉和颅内动脉血流动力学的研究分析[J].东南国防医药，2010，12(5):415-417.
[13]隋春兴，刘俊新，周旭晨，等.冠脉钙化积分在可疑冠心病无创诊断中的临床意义[J].中国老年医学杂志，2011，31(5):867-868.
[14]Kwon HM,Hong BK,Kang TS,et al.Expression of osteopontin in calcified coronary atherosclerotic plaques[J].J Korean Med Sci,2000,15(5):485-493.
[15]Borja F,Andreas K,Frederic P,et al.Osteoglycin expression and localization in rabbittissues and atherosclerotic plaques[J].Mol Cell Biochem,2003,246(1-2):3-11.
[16]Borja F,Maria CF,Javier M,et al.Absence of mimecan causes medial damage associated with atherosclerotic lesions in apoE-decient mice[J].FASEB J,2009,23(4):640-650.
[17]Marzoll A,Melchior-Becker A,Cipollone F,et al.mall leucine-rich proteoglycans in atherosclerotic lesions:Novel targets of chronic statin treatment[J].J Cell Mol Med,2011,15(2):232-243.
[18]汪燕舞，刘红玲，陈智龙.阿托伐他汀对高血压大鼠血管纤维化及结缔组织生长因子的影响[J].中国康复,2010,25(1):6-8.
[19]Berhane BT,Zong C,Liem DA,et al.Cardiovascular-related proteins identified in human plasma by the HUPO plasma proteome project pilot phase[J].Proteomics,2005,5(13):3520-3530.
[20]Petretto E,Sarwar R,Grieve I,et al.Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass[J].Nat Genet,2008,40(5):546-552.
[21]Petretto E,Sarwar R,Grieve I,et al.Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass[J].Nat Genet,2008,40(5):546-552.
[22]Zhang D,Gaussin V,Taffet GE,et al.TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice[J].Nat Med,2000,6(5):556-563.
[23]Ma QY,Zuo CL,Ma JH，et al.Glucocorticoid up-regulates mimecan expression in corticotroph cells[J].Mol Cell Endocrinol,2010,321(2):239-244.
[24]VanAelst N,Swinnen M,Cook SA,et al.Mimecan is an essential regulator of cardiac extracellular matrix integrity after myocardial infarction[J].Eur J Heart Fail Supplements，2010,31(6):167-178.
[25]Barth AS,Kuner R,Buness A,et al.Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies[J].J Am Coll Cardiol,2006,48(8):1610-1617.

相似文献/References:

[1]李 琦,余志龙综述,郑大东审校.他汀类药物在心血管疾病中的临床应用进展[J].医学研究与战创伤救治(原医学研究生学报),2011,13(05):438.
[2]庄 微综述,刘挺松审校.晚期糖基化终末产物受体在心血管疾病中的研究概况[J].医学研究与战创伤救治(原医学研究生学报),2014,16(06):629.[doi:10.3969/j.issn.1672-271X.2014.06.021]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2012-01-20